Adaptive Biotechnologies Insider Sells After Doubling Rally
When a company’s stock doubles and an insider sells a large block, investors should ask: what’s really going on? This...
Timing matters when it comes to retirement planning. Learn when you should start planning to maximize your savings and ensure a secure future.
26,056 articlesWhen a company’s stock doubles and an insider sells a large block, investors should ask: what’s really going on? This...
As Meta Platforms advances a sweeping AI infrastructure plan, the stock remains a focus for investors who see the com...
Workers say their benefits aren’t safety nets but leverage points used to keep them in place. This timely report expl...
Qualcomm expands beyond phones with auto, IoT, and data center momentum, signaling a broad growth cycle for a semicon...
Geopolitical tensions push yields higher, nudging mortgage rates tick higher and complicating spring homebuying for m...
In 2026, a trio of regulated utilities stands out for investors chasing steady cash flow and dividend growth amid rat...
CoreWeave has surged into the AI infrastructure spotlight, but the ride is not risk-free. This article analyzes the g...
Manchester’s mayor is emerging as Labour’s strongest northern voice in a high-stakes leadership contest. This report ...
Bitcoin tops $80,000 again as Canaccord Genuity raises MicroStrategy’s price target to $224, highlighting a move towa...
Nscale raised billions to power Europe’s AI ambitions, but the company now confronts the need to prove it can transla...
A Capitol Hill probe into Epstein-era ties turned volatile this week, with lawmakers veering from policy questions to...
Canoo has begun production of its electric vans, but internal documents show missing parts and late payments that cou...